Vida Mashayekhi

2.1k citations

37 papers · 1.7k indexed · 1 hit paper · h-index 20

Biomedical Engineering top 5%
Pulmonary and Respiratory Medicine top 5%
Molecular Biology
Materials Chemistry top 10%
Organic Chemistry top 10%

Co-authors: Sabrina Oliveira Dominic J. Robinson Demian van Straten Kamaleddin H. M. E. Tehrani Mir‐Jamal Hosseini Mohammad Reza Eskandari Farzad Kobarfard Nathaniel I. Martin
Topics: Photodynamic Therapy Research Studies (10 papers)Nanoplatforms for cancer theranostics (7 papers)Antibiotic Resistance in Bacteria (6 papers)
Cited by: Molecular Medicine Pulmonary and Respiratory Medicine Biomedical Engineering
Journals: PLoS ONE Chemical Communications Journal of Medicinal Chemistry
Partner nations: Netherlands Iran Switzerland

In The Last Decade

Vida Mashayekhi

37 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions

2017 816 citations Demian van Straten, Vida Mashayekhi et al. profile →

Peers

Countries citing papers authored by Vida Mashayekhi

Since Specialization

Citations

This map shows the geographic impact of Vida Mashayekhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vida Mashayekhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vida Mashayekhi more than expected).

Fields of papers citing papers by Vida Mashayekhi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vida Mashayekhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vida Mashayekhi. The network helps show where Vida Mashayekhi may publish in the future.

Co-authorship network of co-authors of Vida Mashayekhi

This figure shows the co-authorship network connecting the top 25 collaborators of Vida Mashayekhi. A scholar is included among the top collaborators of Vida Mashayekhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vida Mashayekhi. Vida Mashayekhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Photoimmuno-antimicrobial therapy for Staphylococcus aureus implant infection 2024 ·PLoS ONE ·(unknown),Sabrina Oliveira,(unknown),(unknown),Vida Mashayekhi,Irati Beltrán Hernández,Jos A. G. van Strijp,(unknown),Piet C. Aerts,H. Charles Vogely,Harrie Weinans,Bart C. H. van der Wal	1
2	The RNA binding protein IGF2BP2/IMP2 alters the cargo of cancer cell-derived extracellular vesicles supporting tumor-associated macrophages 2024 ·Cell Communication and Signaling ·Vida Mashayekhi,(unknown),(unknown),Ernesto Aparicio‐Puerta,(unknown),(unknown),Мarcus A. Koch,(unknown),Nicole Ludwig,(unknown),Andreas Keller,Rolf Müller,Gregor Fuhrmann,Jessica Hoppstädter,Alexandra K. Kiemer	4
3	Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in an In Vitro Model of Tumour-Associated Macrophages 2023 ·Pharmaceutics ·(unknown),Britta Diesel,(unknown),Emmanuel Ampofo,(unknown),Vida Mashayekhi,Marc Schneider,Alexandra K. Kiemer	2
4	Nanobody-Targeted Photodynamic Therapy: Nanobody Production and Purification 2022 ·Methods in molecular biology ·Vida Mashayekhi,Erik van Schooten,Paul M.P. van Bergen en Henegouwen,Marta M. Kijanka,Sabrina Oliveira	5
5	Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma 2021 ·Theranostics ·Vida Mashayekhi,(unknown),Marcel H.A.M. Fens,Gerard C. Krijger,Lodewijk A.A. Brosens,Sabrina Oliveira	16
6	Mechanistic Investigations of Metallo‐β‐lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition** 2021 ·ChemMedChem ·(unknown),Kamaleddin H. M. E. Tehrani,(unknown),Matthijs J. van Haren,Vida Mashayekhi,Nathaniel I. Martin	24
7	Cephalosporin Prodrug Inhibitors Overcome Metallo‐β‐Lactamase Driven Antibiotic Resistance 2020 ·Chemistry - A European Journal ·Matthijs J. van Haren,Kamaleddin H. M. E. Tehrani,(unknown),(unknown),(unknown),Vida Mashayekhi,Nathaniel I. Martin	19
8	Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging 2020 ·Theranostics ·Henriëtte S. de Bruijn,Vida Mashayekhi,(unknown),Pieter B. A. A. van Driel,Gustav J. Strijkers,P. J. van Diest,Clemens W.G.M. Löwik,Ann L.B. Seynhaeve,Timo L.M. ten Hagen,Jeanine J. Prompers,Paul M.P. van Bergen en Henegouwen,Dominic J. Robinson,Sabrina Oliveira	32
9	Aminocarboxylic acids related to aspergillomarasmine A (AMA) and ethylenediamine-N,N′-disuccinic acid (EDDS) are strong zinc-binders and inhibitors of the metallo-beta-lactamase NDM-1 2020 ·Chemical Communications ·Kamaleddin H. M. E. Tehrani,Haigen Fu,(unknown),Vida Mashayekhi,(unknown),Matthijs J. van Haren,Gerrit J. Poelarends,Nathaniel I. Martin	18
10	Novel Carbapenemases FLC-1 and IMI-2 Encoded by an Enterobacter cloacae Complex Isolated from Food Products 2019 ·Antimicrobial Agents and Chemotherapy ·Michael S. M. Brouwer,Kamaleddin H. M. E. Tehrani,Michel Rapallini,Yvon Geurts,Arie Kant,Frank Harders,Vida Mashayekhi,Nathaniel I. Martin,Alex Bossers,Dik Mevius,Ben Wit,Kees Veldman	21
11	Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR‐targeted photoimmunotherapy in human head and neck cancer cell lines 2018 ·Lasers in Surgery and Medicine ·Wei Peng,Henriëtte S. de Bruijn,Eric Farrell,Mouldy Sioud,Vida Mashayekhi,Sabrina Oliveira,(unknown),Jan L.N. Roodenburg,Max J. H. Witjes,Dominic J. Robinson	21
12	oncologic photodynamic therapy: basic principles, current clinical status and future directions 2017 ·Journal of Investigative Dermatology ·Demian van Straten,Vida Mashayekhi,Henriëtte S. de Bruijn,Sabrina Oliveira,Dominic J. Robinson	1
13	Mitochondria as a Target for the Cardioprotective Effects of Cydonia oblonga Mill. and Ficus carica L. in Doxorubicin-Induced Cardiotoxicity 2017 ·Drug Research ·(unknown),Mir‐Jamal Hosseini,(unknown),(unknown),Mohammad Kamalinejad,Vida Mashayekhi,Seyed Hossein Hosseini,(unknown),Jalal Pourahmad,Mohammad Reza Eskandari	23
14	Mitochondrial oxidative stress and dysfunction induced by isoniazid: study on isolated rat liver and brain mitochondria 2015 ·Drug and Chemical Toxicology ·(unknown),Mohammad Reza Eskandari,Vida Mashayekhi,Kamaleddin H. M. E. Tehrani,(unknown),Parvaneh Naserzadeh,Mir‐Jamal Hosseini	60
15	Mechanistic approach for the toxic effects of perfluorooctanoic acid on isolated rat liver and brain mitochondria 2015 ·Human & Experimental Toxicology ·Vida Mashayekhi,Kamaleddin H. M. E. Tehrani,Mahmoud Hashemzaei,Kaveh Tabrizian,Jafar Shahraki,Mir‐Jamal Hosseini	52
16	Induction of mitochondrial permeability transition (MPT) pore opening and ROS formation as a mechanism for methamphetamine-induced mitochondrial toxicity 2013 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Vida Mashayekhi,Mohammad Reza Eskandari,Farzad Kobarfard,(unknown),Mir‐Jamal Hosseini	52
17	Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones 2013 ·Archives of Pharmacal Research ·Vida Mashayekhi,Kamaleddin H. M. E. Tehrani,(unknown),Soroush Sardari,Farzad Kobarfard	22
18	Synthesis of thioether derivatives of quinazoline-4-one-2-thione and evaluation of their antiplatelet aggregation activity 2013 ·Archives of Pharmacal Research ·(unknown),(unknown),Kamaleddin H. M. E. Tehrani,Vida Mashayekhi,Farzad Kobarfard	21
19	Toxicity of valproic acid in isolated rat liver mitochondria 2013 ·Toxicology Mechanisms and Methods ·(unknown),Mohammad Reza Eskandari,Vida Mashayekhi,(unknown),Mir‐Jamal Hosseini	60
20	Synthesis of Novel Indole Hydrazone Derivatives and Evaluation of Their Antiplatelet Aggregation Activity 2012 ·Chemical and Pharmaceutical Bulletin ·Vida Mashayekhi,Kamaleddin H. M. E. Tehrani,Salimeh Amidi,Farzad Kobarfard	40

About Vida Mashayekhi

Vida Mashayekhi is a scholar working on Molecular Medicine, Toxicology and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 1.7k indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (10 papers), Nanoplatforms for cancer theranostics (7 papers) and Antibiotic Resistance in Bacteria (6 papers). The work is most often cited by research in Molecular Medicine (107 citations), Pulmonary and Respiratory Medicine (685 citations) and Biomedical Engineering (760 citations). Vida Mashayekhi has collaborated with scholars based in Netherlands, Iran and Switzerland. Frequent co-authors include Sabrina Oliveira, Dominic J. Robinson, Demian van Straten, Kamaleddin H. M. E. Tehrani, Mir‐Jamal Hosseini, Mohammad Reza Eskandari, Farzad Kobarfard, Nathaniel I. Martin, Matthijs J. van Haren and Soroush Sardari. Their work appears in journals such as PLoS ONE, Chemical Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact